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Abstract
Background: Patients with morbid obesity have an increased risk for anxiety and depression. The "duodenal switch" is 
perhaps the most effective obesity surgery procedure for inducing weight loss. However, to our knowledge, data on 
symptoms of anxiety and depression after the duodenal switch are lacking. Furthermore, it has been hypothesized that 
self-reported physical health is the major predictor of symptoms of depression in patients with morbid obesity. We 
therefore investigated the symptoms of anxiety and depression before and after the duodenal switch procedure and 
whether post-operative changes in self-reported physical health were predictive of changes in these symptoms.
Methods: Data were assessed before surgery (n = 50), and one (n = 47) and two (n = 44) years afterwards. Symptoms 
of anxiety and depression were assessed by the "Hospital Anxiety and Depression Scale", and self-reported physical 
health was assessed by the "Short-Form 36" questionnaire. Linear mixed effect models were used to investigate 
changes in the symptoms of anxiety and depression. Correlation and linear multiple regression analyses were used to 
study whether changes in self-reported physical health were predictive of post-operative changes in the symptoms of 
anxiety and depression.
Results: The symptom burden of anxiety and depression were high before surgery but were normalized one and two 
years afterwards (P < 0.001). The degree of improvement in self-reported physical health was associated with 
statistically significant reductions in the symptoms of anxiety (P = 0.003) and depression (P = 0.004).
Conclusions: The novelty of this study is the large and sustained reductions in the symptoms of anxiety and 
depression after the duodenal switch procedure, and that these changes were closely associated with improvements 
in self-reported physical health.
Introduction
Patients suffering from morbid obesity, have an increased
risk for symptoms of anxiety and depression [1]. Interest-
ingly, studies have shown that obesity surgery may lead to
significant relief of such symptoms, but also to small
improvements or improvements that wane with time [2].
Among obesity surgery procedures, the "duodenal
switch" is perhaps the most effective for inducing weight
loss [3]. However, to our knowledge, data on symptoms of
anxiety and depression after this procedure are lacking.
Since different bariatric procedures may give raise to pos-
itive effects on health as well as side-effects, it has been
argued that each procedure should be carefully docu-
mented longitudinally [4,5].
Another interesting issue is the puzzling finding that
although the degree of weight loss after obesity surgery
may predict changes in symptoms of anxiety and depres-
sion, the size of the effect has been rather small [6]. The
body mass index (BMI) has also been shown to be a poor
predictor of symptoms of depression in patients seeking
obesity surgery [7-9]. One theory is that obesity mainly
influences mental health through its impact on self-
reported physical health, which is defined as physical
functioning, physical role functioning, and bodily pain
[7]. Some data seems to support this theory, since symp-
toms of depression have only been shown to be high
among patients with morbid obesity who also had poor
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Page 2 of 7self-reported physical health, regardless of BMI [7]. Qual-
itative interviews have also revealed that reduced self-
reported physical health is considered to be a substantial
burden in patients undergoing obesity surgery [10], Fur-
thermore, a survey showed that depressed patients with
morbid obesity were primary motivated by their poor
physical health to seek obesity surgery [11]. Although
there are no reasons to doubt that reciprocity exists
between obesity, self-reported physical health, and
depression [12,13], depressive symptomatology has been
reported to flow mainly from poor physical health to
depression rather than in the reverse direction [14]. In
conclusion, there is a lack of knowledge about the predic-
tors of symptoms of anxiety and depression after obesity
surgery. Such data may shed more light on how bariatric
surgery influences mental health.
Therefore, this study aimed to prospectively assess the
symptoms of anxiety and depression in a sample of
patients who were treated with the duodenal switch pro-
cedure for morbid obesity and to determine whether
changes in self-reported physical health was predictive
for changes in such symptoms. We hypothesized that
anxiety and depression would improve following duode-
nal switch and that these changes would be related to
changes in self-reported physical health.
Methods
Patients and study design
The first 51 patients with morbid obesity who were
accepted for obesity surgery at Førde Central Hospital
were invited to participate in the study. Our bariatric sur-
gery program was initiated in 2001, and the inclusion cri-
teria included BMI ≥ 40.0 or 35.0-39.9 with obesity-
related co-morbidities, age 18-60, no alcohol or drug
problems, no active psychosis, and failure to lose weight
through other methods. Power calculations were per-
formed using a two-sided paired test (predicted effect
size = 0.6, providing 90% power, p < 0.05) indicating that
at least 32 paired observations would be required to
detect changes in the anxiety and depression scores. Data
were assessed before surgery (T0), one-year after surgery
(T1), and two-years after surgery (T2).
The treatment: duodenal switch
The duodenal switch (open approach) is performed by
resecting the greater curvature of the stomach, leaving a
narrow gastric tube of 100 to 120 ml along the lesser cur-
vature. The pylorus is left intact, and the duodenum is
divided 3 to 4 cm distal to the pylorus. The small bowel is
usually divided 250 cm above the coecum, and the proxi-
mal end of the distal small bowel is anastomosed to the
proximal end of duodenum (alimentary limb). The distal
end of the proximal small bowel is usually anastomosed
to the alimentary limb 75 to 100 cm above the coecum
(common limb). Due to the malabsorption resulting from
the procedure, patients are encouraged to eat a high pro-
tein diet and to take prescribed daily doses of vitamins
and minerals.
Demographic characteristics and clinical data
Data were obtained using a standardized form. The
patients' age, gender, marital status, employment status,
and educational level were noted. A history of anxiety or
depression was considered to be present if the patient's
general physician confirmed the diagnosis and the patient
was on documented treatment. Body weight was mea-
sured in light clothing without shoes to the nearest 0.1 kg.
Height was measured in a standing position without
shoes to the nearest 0.01 m. BMI was calculated as weight
divided by height squared (kg/m2).
Symptoms of anxiety and depression
Information on symptoms of anxiety and depression were
assessed using the "Hospital Anxiety and Depression
Scale" (HADS), a self-report questionnaire comprised of
14 items, with seven items assessing anxiety and seven
assessing depression [15]. No items related to somatic
issues were included, as the questionnaire was designed
to assess symptoms of anxiety and depression in the
physically ill. The items were scored on a four-point scale
from zero (not present) to three (considerable). The item
scores were added, giving sub-scale scores on the anxiety
scale and the depression scale from zero to 21. A lower
score represented better mental health. The HADS has
shown good case-finding properties in primary care and
hospital settings for anxiety and depression according to
the Diagnostic and Statistical Manual of Mental Disor-
ders and International Classification of Diagnoses. A cut-
off score of 8 points on both subscales was found to give
an optimal balance between sensitivity and specificity,
with both parameters at about 0.80 for depression and
anxiety [16]. The HADS has been judged to be well suited
for detecting mood disorders among the obese, and have
shown good responsiveness to change in patients oper-
ated for morbid obesity [6]. Population norm data on the
HADS was obtained from the Nord-Trøndelag Health
Study (HUNT) in Norway (1995-1997), which was com-
prised of 57,616 participants aged 20-89 years (53%
female)[17].
Self-reported physical health
Information on self-reported physical health was
assessed by the Short Form-36, which is a well-estab-
lished self-administrated generic measure of the health
burden of chronic diseases [18,19]. The Short Form-36
data were used to calculate a physical summary score
known as the physical component summary (PCS), which
correlates most highly with the subscales for physical
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Based on conceptual considerations [20], we chose the
oblique method to calculate the PCS, which allowed for
the correlation of physical and mental health. We also
calculated the mental component summary (MCS)
according to the same method. The basic version of the
SF Health Outcomes™ Scoring Software (Quality Metric
Inc. Lincoln, USA) was used to calculate the summary
scores.
Statistics
The patients' HADS data were calculated as means and
standard deviations, and as means for the population
norm. The number of subjects with HADS scores ≥ 8
points was also assessed. The HADS scores of the popu-
lation norm were adjusted by age and gender to reflect
the same distribution as in our study sample. The method
for this adjustment has been described elsewhere [21].
We calculated effect sizes to illustrate the differences in
HADS scores between patients and the population norm
by subtracting the mean score of the population norm
from the mean score of the patient group, divided by the
standard deviation of the patient group. Effect sizes were
judged against the standard criteria proposed by Cohen
[22]: trivial (<0.2), small (0.2 to <0.5), moderate (0.5 to
<0.8), and large (≥ 0.8). Mixed-effect models were used to
calculate repeated mean changes and 95% CIs for the
HADS scores from T0 to T1 and T2. Correlation analyses
(Pearson's r) and multiple linear regression analyses were
used to investigate predictors for changes in the HADS
scores from T0 to T2. The choice of variables in the mul-
tiple regression analysis was made based on theoretical
considerations and previous research [8]. A two tailed p-
value of < .05 was considered statistically significant. The
mixed linear analyses were conducted with the statistical
program R (the R Foundation for Statistical Computing,
Vienna, Austria). The remaining analyses were per-
formed using the statistical program SPSS for Windows,
version 15.0 (SPSS Inc., Chicago, USA).
Ethics
This investigation conforms to the principles outlined in
the Declaration of Helsinki. The study protocol was
approved by the Regional Committee of Ethics in Medi-
cine, West-Norway (registration number: 234.03).
Results
Informed consent was obtained from all the 51 partici-
pants who were invited to participate in the study. How-
ever, one patient did not complete the HADS
questionnaire at T0 and was excluded from the study. Of
the remaining 50 patients, the mean age was 37.9 ± 7.9
years and 56% were women. Other characteristics of the
patients are presented in table 1 Forty-seven patients
(94%) completed the HADS at T1 and 44 (88%) at T2. The
six patients who did not complete the HADS at T2 had
very similar characteristics compared to the rest of the
sample (data not shown). The HADS anxiety score,
HADS depression score, PCS and MCS were significantly
correlated with each other at T0 (Table 2) and at T1/T2
(data not shown). Using all available data, the mean Δ
BMI from T0 to T2 was -20.0 units; 95% CI, -17.9 to -
22.1; P < 0.001. The HADS scores at T0 did not predict
changes in BMI after the operation (Ps <0.652). The mean
Δ PCS score from T0 to T2 was 21.3 points; 95% CI, 17.6
to 25.0; P < 0.001, and the mean Δ MCS was 12.9 points;
95% CI, 8.1 to 17.7; P < 0.001.
HADS scores before and after the duodenal switch
The HADS scores at T0 showed that the patients had
considerably more symptoms of anxiety and depression
than the population norm (Table 3). The patients' effect
sizes at T1 and T2 indicated that their scores had normal-
ized and that the symptoms of depression had improved
somewhat more than the symptoms of anxiety (Table 3).
The prevalence of HADS scores ≥ 8 points also decreased
after surgery. This was reflected by statistically significant
changes in the mixed effects analysis (Ps < 0.001) (Figure
1).
However, the number of patients being treated for anxi-
ety and depression were approximately the same at T0
and T2 (Table 1). The prevalence of HADS anxiety scores
≥ 8 points decreased only slightly from 85.7% to 71.4%
from T0 to T2 in the patients who were being treated for
anxiety before surgery (n = 7). For patients being treated
for depression before surgery (n = 12), the prevalence of
HADS depression scores ≥ 8 points decreased from
75.0% to 8.3%. Higher HADS scores were associated with
being on treatment for anxiety and depression both
before and after surgery (Ps < 0.05). The patients being
treated for anxiety and depression had poorer PCS scores
than the rest of the patients at T0 (Ps < 0.05, but not at T2
(Ps > 0.18).
Predicting changes in symptoms of anxiety and depression 
after the duodenal switch
Correlation analyses showed that a higher Δ PCS score
was significantly correlated with a greater decrease in the
Δ HADS scores, but Δ BMI was not (Table 4). In the mul-
tiple linear regression analysis, a higher Δ PCS score was
predictive of greater decreases in the Δ HADS scores for
anxiety (non-standardized reg. coeff, -0.18; 95% CI, -0.29
to -0.06; P = 0.003) and depression (non-standardized
reg. coeff, -0.17; 95% CI, -0.27 to -0.06; P = 0.004) after
adjusting for age, gender, and the initial PCS and HADS
scores.
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This is, to our knowledge, the first study to demonstrate a
large and sustained reduction in the symptoms of anxiety
and depression after the duodenal switch procedure, and
that these changes were closely associated with improve-
ments in self-reported physical health. Although this
study cannot establish causality, it supports the hypothe-
sis that improved self-reported physical health is a mech-
anism by which the symptoms of anxiety and depression
are decreased in patients undergoing obesity surgery.
Even though studies have shown reductions in symp-
toms of anxiety and depression after different types of
obesity surgery [2,6], the results in the present study are
particularly promising. This study adds to the body of
data that the duodenal switch is associated with benefi-
cial effects on a range of aspects of health-related quality
of life [23-25], despite that one common side-effect after
this operation is malodorous flatus [5]. Thus, the side-
effects of the duodenal switch do not seem disturbing
enough to override the patient's health appraisals. How-
ever, the maintenance of an adequate weight loss seems
to be crucial for long-term symptom relief [6]. The duo-
denal switch may therefore be particularly effective, since
it has the best long-term weight loss of any obesity opera-
tion [3]. However, longer follow-up is required to investi-
gate this issue.
Surprisingly, we found that the number of patients who
were being treated for anxiety and depression was quite
stable during the study. We can only speculate on the rea-
sons for this finding. The data showed that the patients
who were being treated for anxiety before surgery contin-
ued to have substantial symptom burdens of anxiety
afterwards. However, it is possible that their anxieties
were unrelated to obesity to begin with. On the contrary,
the patients who were being treated for depression before
surgery had very low symptom burdens of depression
after surgery. Unfortunately we had no specific informa-
tion regarding how the general physicians had evaluated
the need for continued treatment for depression.
That the symptoms of depression were somewhat more
reduced than the symptoms of anxiety is in agreement
with some previous work [26,27]. Although symptoms of
anxiety often are reduced after obesity surgery, the
patients may face challenges related to self-concept,
social relations, and skill acquisition [28]. How patients
cope with these matters might influence different health
outcomes, perhaps anxiety in particular. It has also been
reported that some patients may fear regaining their
weight [26].
Table 1: Patient characteristics (n = 50).
Variables T0 T1 T2
Body mass index 51.7 ± 7.5 32.7 (5.8) 31.7 (5.7)
Physical component summary 31.9 ± 9.8 52.2 ± 9.5 53.4 ± 8.6
Mental component summary 37.4 ± 12.4 51.8 ± 11.5 50.2 ± 12.3
Married/cohabitation 25 (50.0) 29 (58.0) 25 (50.0)
Education (≥ 13 years) 13 (26.0) 13 (26.0) 13 (26.0)
Employed 27 (54.0) 27 (54.2) 33 (66.0)
On treatment for anxiety 7 (14.0) 6 (12.0) 7 (14.0)
On treatment for depression 12 (24.0) 12 (24.0) 15 (30.0)
Note. T0 is before surgery, T1 is one year after surgery, and T2 is two years after surgery. Age, body mass index, the physical component 
summary and the mental component summary are presented as means ± standard deviations, while the remaining variables are presented 
as crude numbers and (percentages). Data were complete for all variables except for the physical component summary and the mental 
component summary (T2, n = 47 and T2, n = 41).
Table 2: Descriptive statistics and correlations among HADS data and the SF-36 summary scores before surgery (N = 50)
Mean ± SD HADS-D PCS MCS
HADS anxiety 7.8 ± 4.4 0.71 *** -0.44** -0.73***
HADS depression 6.3 ± 4.6 -0.49 *** -0.78 ***
PCS 31.9 ± 9.8 0.53 ***
MCS 37.4 ± 12.4
Note. HADS: hospital anxiety and depression scale. PCS: physical cumulative summary. MCS: mental cumulative summary. *P < 0.05, ** P < 
0.01, *** P < 0.001.
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was associated with an approximately 0.17 point decrease
in the Δ HADS scores can be regarded as clinically signif-
icant, since the average Δ PCS score was 21.3 points.
However, longitudinal data on this issue is scarce. In one
study, improvement in self-reported physical health (the
orthogonal physical component summary score of the
SF-36) was significantly correlated with a decrease in the
"Beck Depression Inventory Score" after lap band surgery
[8]. Unfortunately, the change in the self-reported physi-
cal health score was not included in the multiple regres-
sion analysis in that study.
One particular study seems to contradict the hypothe-
sis that self-reported physical health is a major predictor
of anxiety and depression. Improvements in symptoms of
depression were documented as early as 2 to 4 weeks
after Roux-en-Y gastric bypass, despite the fact that no
changes in self-reported physical health had occurred
[29]. However, this rapid improvement may have been
caused by a realistic hope that a long-term disability was
about to be relieved. Thus, we hypothesize that sustained
relief of symptoms of depression will only be observed if
an improvement in self-reported physical health also
occurs.
The finding that that the Δ BMI was not significantly
correlated with the Δ HADS scores may be related to the
fact that the patients' weight loss could have exceeded a
threshold above which few differences in symptoms of
anxiety and depression were observed. For example, in
the SOS study, the degree of weight loss predicted a
greater improvement in the HADS depression score after
bariatric surgery [6]. This effect was especially large in
patients who lost ≥ 30% of their initial weight, which
occurred in 12% of the patients. In our study, 78% of the
patients lost ≥ 30% of their initial weight. Thus, our data
displayed large effect sizes with little variability.
Strengths of this study are the validity of the HADS and
the Short Form-36 and the large changes in these mea-
sures after surgery. It is important to note that the HADS
questionnaire is not "contaminated" with somatic issues
to avoid circular reasoning [15]. There are also clear limi-
tations to the study. First, this was not a randomized con-
trolled trail (RCT). Some of the changes in symptoms of
anxiety and depression seen in this study could therefore
be partly due to other things than the surgery. However, it
has been argued that due to practical and ethical reasons,
RCTs are not usually an appropriate standard of evidence
for evaluating most surgical treatments, which of neces-
sity must rely on prospective cohort studies [30]. Second,
the regression models were quite simple and the sample
size was relatively small. Unmeasured variables not
included in our analyses could have confounded the
Table 3: Hospital Anxiety and Depression Scale (HADS) data in the patient group before and after surgery as compared to 
the population norm.
T0
(n = 50)
T1
(n = 47)
T2
(n = 44)
Population norm
(n = 57616)
HADS anxiety
Mean ± SD 7.8 ± 4.4 5.1 ± 4.0 5.0 ± 3.8 4.4
Effect size 0.77 0.18 0.16 Reference
Score ≥ 8 points (%) 50.0 27.2 22.7 16.1
HADS depression
Mean ± SD 6.3 ± 4.6 2.1 ± 2.3 2.2 ± 3.0 3.0
Effect size 0.72 -0.39 -0.27 Reference
Score ≥ 8 points (%) 36.0 2.1 4.5 8.1
Note. T0 is before surgery, T1 is one year after surgery, and T2 is two years after surgery. The population norm scores are adjusted for age and 
gender. Effect size is calculated by subtracting the mean score of the population norm from the mean score of the patient group divided by 
the standard deviation of the patient group. Effect sizes <0.2 are considered trivial compared to the population norm. Effect sizes from 0.2 to 
<0.5 are considered small, from 0.5 to <0.8 as moderate, and ≥ 0.8 as large. The effects size of the HADS scores can be either zero (identical 
mean scores in both populations), positive (worse score than the norm population), or negative (better score than the norm population).
Figure 1 Mixed effect model analysis: mean changes and 95 CIs in 
the Hospital Anxiety and Depression Scale (HADS) scores after 
surgery. T0 is before surgery, T1 is one year after surgery, and T2 is two 
years after surgery. *** P < 0.001.
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Obesity-related stigma is for instance of particular inter-
est as a predictor for symptoms of depression [31]. How-
ever, it is unclear to what degree this perceived stigma is
an indicator of depression, a cause, or both. This topic
should be further examined in prospective studies. Fur-
thermore, a larger sample size could have allowed us to
use structural equation modeling to examine the associa-
tion between self-reported physical health, anxiety, and
depression. Although this method cannot establish cau-
sality, it can be a useful tool for testing for reciprocal
effects [14]. Finally, we lacked standardized data on anxi-
ety and depression based on a structured clinical inter-
view, as well as an evaluation of the need for continued
treatment. Thus, we cannot properly address the finding
that no patients were taken off treatment for anxiety and
depression despite having better HADS scores.
Conclusions
In conclusion this study indicated that the duodenal
switch was associated with a large reduction in symptoms
of anxiety and depression. Although we acknowledge that
the causal mechanisms for the observed improvements in
symptoms of anxiety and depression can be complex, the
main mechanism at play was likely weight loss-induced
improvements in self-reported physical health. If this
mechanism is correct, it is important to keep in mind
when we provide care and treatment to our patients with
morbid obesity who suffers from anxiety or depression.
Future work should be performed to confirm the findings
in this study and investigate other possible mechanisms.
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